Hepatitis C -- identifying patients with progressive liver injury
- PMID: 16447261
- DOI: 10.1002/hep.21065
Hepatitis C -- identifying patients with progressive liver injury
Abstract
Hepatitis C follows a variable course with some patients developing progressive liver fibrosis, cirrhosis and hepatocellular carcinoma, while others have minimal or no significant liver disease after decades of infection. Studies have identified both host and viral factors associated with disease progression. The importance of general factors such as age at infection, gender, immune status and alcohol consumption has long been recognized; however recently, polymorphisms in a wide array of genes have also been shown to be associated with progressive fibrosis. How specific viral proteins may contribute to disease progression has also been studied. This review highlights what is currently known about the factors associated with progressive liver injury in patients with hepatitis C. A greater understanding of the determinants of disease progression will hopefully lead to improved utilization of existing treatments and ultimately may aid in identification of new therapeutic targets.
Similar articles
-
Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.Minerva Gastroenterol Dietol. 2005 Mar;51(1):31-46. Minerva Gastroenterol Dietol. 2005. PMID: 15756144 English, Italian.
-
Natural history of chronic hepatitis C.Ital J Gastroenterol Hepatol. 1999 Jan-Feb;31(1):28-44. Ital J Gastroenterol Hepatol. 1999. PMID: 10091101 Review.
-
Natural history: the importance of viral load, liver damage and HCC.Best Pract Res Clin Gastroenterol. 2008;22(6):1063-79. doi: 10.1016/j.bpg.2008.11.006. Best Pract Res Clin Gastroenterol. 2008. PMID: 19187867 Review.
-
[Hepatitis B and C: natural course of disease].Acta Med Croatica. 2005;59(5):389-92. Acta Med Croatica. 2005. PMID: 16381232 Croatian.
-
Effect of alcohol, cigarette smoking, and diabetes on occurrence of hepatocellular carcinoma in patients with transfusion-acquired hepatitis C virus infection who develop cirrhosis.Eur J Gastroenterol Hepatol. 2008 Jul;20(7):674-9. doi: 10.1097/MEG.0b013e3282f762e1. Eur J Gastroenterol Hepatol. 2008. PMID: 18679071
Cited by
-
Interferon sensitivity-determining region of hepatitis C virus influences virus production and interferon signaling.Oncotarget. 2017 Dec 21;9(5):5627-5640. doi: 10.18632/oncotarget.23562. eCollection 2018 Jan 19. Oncotarget. 2017. PMID: 29464023 Free PMC article.
-
Recognition of genetic factors influencing the progression of hepatitis C : potential for personalized therapy.Mol Diagn Ther. 2008;12(4):209-18. doi: 10.1007/BF03256286. Mol Diagn Ther. 2008. PMID: 18652517 Review.
-
Predictors of Significant Liver Fibrosis in People with Chronic Hepatitis C Who Inject Drugs in the Czech Republic.Life (Basel). 2023 Apr 2;13(4):932. doi: 10.3390/life13040932. Life (Basel). 2023. PMID: 37109461 Free PMC article.
-
APASL consensus statements and management algorithms for hepatitis C virus infection.Hepatol Int. 2012 Apr;6(2):409-35. doi: 10.1007/s12072-012-9342-y. Epub 2012 Mar 1. Hepatol Int. 2012. PMID: 26201405
-
Heterozygous beta-globin gene mutations as a risk factor for iron accumulation and liver fibrosis in chronic hepatitis C.Gut. 2007 May;56(5):693-8. doi: 10.1136/gut.2006.106641. Epub 2006 Nov 29. Gut. 2007. PMID: 17135308 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources